NIH-funded research NIH-funded research

Modeling how cells regulate non-genetic variability in human cells

Official title: Modeling transcriptional and post-transcriptional systems for regulating non-genetic heterogeneity in mammalian cells

Funded at University of Texas Dallas · NIH-11418942 · Data updated 2026-11-12

Aims to understand how random differences between cells affect things like stem cell decisions and cancer cell behavior, using math models and experiments in human cell systems.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Texas Dallas
NIH-funded
Lab location1 site (Richardson, United States)
Project startJune 1, 2023
Project endMay 31, 2028
Funding year2026
Award (this year)$395,625
NIH project number5R35GM149531-05
Project IDNIH-11418942 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with cancers or degenerative disorders where cell heterogeneity impacts disease behavior and treatment outcomes, though this grant itself is a basic science project.

Less likely to help

Direct patient benefit may not be immediate, as the study is primarily laboratory and modeling work.

What this research studies

This project uses mathematical models and new ways to analyze gene networks and expression data to explain why non-genetic differences among mammalian cells persist and influence outcomes like differentiation and drug resistance. It combines theory with experiments in motor neuron differentiation and epithelial-mesenchymal transition to test a new framework called a diverging oscillator. The work could help explain why cell populations behave differently even when their genetic material is the same. By linking computational insights with laboratory data, it seeks to reveal mechanisms driving cellular heterogeneity in cancer and degeneration-related processes.

Why it matters

Potential benefit: Better understanding of how cell-to-cell differences contribute to disease progression and treatment resistance, potentially guiding future therapies.

How similar studies have gone: Previous research has shown that non-genetic heterogeneity influences cell fate and drug responses, suggesting potential for meaningful insights in this area.

Where this research is happening

  • University of Texas Dallas
    Richardson, United States
    Active

Researchers

  • Principal investigator: Hong, Tian — University of Texas Dallas
  • Study coordinator: Hong, Tian

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.